Please use this identifier to cite or link to this item:
|Title:||Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors|
Granja, Sara Costa
Longatto Filho, Adhemar
Faria, André M.
Fragoso, Maria C. B. V.
Lovisolo, Silvana M.
Lerário, Antonio M.
Almeida, Madson Q.
Zerbini, M. C. N.
|Publisher:||Impact Journals LLC|
|Abstract(s):||Adrenocortical carcinomas (ACCs) are complex neoplasias that may present unexpected clinical behavior, being imperative to identify new biological markers that can predict patient prognosis and provide new therapeutic options. The main aim of the present study was to evaluate the prognostic value of metabolism-related key proteins in adrenocortical carcinoma. The immunohistochemical expression of MCT1, MCT2, MCT4, CD147, CD44, GLUT1 and CAIX was evaluated in a series of 154 adult patients with adrenocortical neoplasia and associated with patients’ clinicopathological parameters. A significant increase in was found for membranous expression of MCT4, GLUT1 and CAIX in carcinomas, when compared to adenomas. Importantly MCT1, GLUT1 and CAIX expressions were significantly associated with poor prognostic variables, including high nuclear grade, high mitotic index, advanced tumor staging, presence of metastasis, as well as shorter overall and disease free survival. In opposition, MCT2 membranous expression was associated with favorable prognostic parameters. Importantly, cytoplasmic expression of CD147 was identified as an independent predictor of longer overall survival and cytoplasmic expression of CAIX as an independent predictor of longer disease-free survival. We provide evidence for a metabolic reprogramming in adrenocortical malignant tumors towards the hyperglycolytic and acid-resistant phenotype, which was associated with poor prognosis.|
|Appears in Collections:||ICVS - Artigos em Revistas Internacionais com Referee|